Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress

Astragaloside IV suppresses inflammatory response via suppression of NF-κB, and MAPK signalling in human bronchial epithelial cells

(2020) Hsi-Lung Hsieh et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Astragaloside IV as Potential Antioxidant Against Diabetic Ketoacidosis in Juvenile Mice Through Activating JNK/Nrf2 Signaling Pathway

(2020) Li-li Deng   ARCHIVES OF MEDICAL RESEARCH

GanMeijian ameliorates lipid accumulation and oxidative damage in alcoholic fatty liver disease in Wistar rats

(2020) Yuhua Li et al.   LIFE SCIENCES

Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation

(2019) Zhongsheng Zhu et al.   MEDICAL SCIENCE MONITOR

Protective effects of the suppressed NF‐κB/TLR4 signaling pathway on oxidative stress of lung tissue in rat with acute lung injury

(2019) Ze‐Ming Zhang et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model

(2019) Cong Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation

(2018) Chunyi Wang et al.   Frontiers in Pharmacology

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

(2018) Fei Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway

(2018) Lei Li et al.   MOLECULES

Alcoholic liver disease

(2018) Helmut K. Seitz et al.   Nature Reviews Disease Primers

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway

(2018) Zhijie Zhang et al.   MEDICAL SCIENCE MONITOR

Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro

(2017) Xiangjun Zhou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production

(2017) Zhenhua Ma et al.   PLoS One

Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

(2017) Sukhpreet Singh et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Activation of apoptosis signalling pathways by reactive oxygen species

(2016) Maureen Redza-Dutordoir et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Establishment of an alcoholic fatty liver disease model in mice

(2016) Peizhu Tan et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver

(2015) Xinwei Li et al.   CELLULAR SIGNALLING

Pyocyanin Stimulates Quorum Sensing-Mediated Tolerance to Oxidative Stress and Increases Persister Cell Populations in Acinetobacter baumannii

(2014) Nidhi Bhargava et al.   INFECTION AND IMMUNITY

Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review

(2014) Imen Belhadj Slimen et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF-κB pathway under high glucose conditions

(2014) LI SUN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal

(2014) S. Salzano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver

(2014) Jinyao Liu   WORLD JOURNAL OF GASTROENTEROLOGY

Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression

(2013) Dingkun Gui et al.   CYTOKINE

Role of oxidative stress in the pathogenesis of alcohol-induced liver disease

(2013) B. Sid et al.   FREE RADICAL RESEARCH

Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease

(2011) Ariel E. Feldstein et al.   ANTIOXIDANTS & REDOX SIGNALING

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

(2010) E. A. Rakha et al.   JOURNAL OF CLINICAL PATHOLOGY

Role of oxidative stress in alcohol-induced liver injury

(2009) Arthur I. Cederbaum et al.   ARCHIVES OF TOXICOLOGY